Neuroprotection of Rotenone-Induced Parkinsonism by Ursolic Acid in PD Mouse Model

2020 ◽  
Vol 19 (7) ◽  
pp. 527-540 ◽  
Author(s):  
Walia Zahra ◽  
Sachchida Nand Rai ◽  
Hareram Birla ◽  
Saumitra Sen Singh ◽  
Aaina Singh Rathore ◽  
...  
Keyword(s):  
Oxidative Stress ◽  
Mouse Model ◽  
Ursolic Acid ◽  
Antioxidant Activities ◽  
Clinical Intervention ◽  
Bioactive Compound ◽  
Nuclear Factor Κb ◽  
Interleukin 10 ◽  
Biochemical Tests ◽  
Control Drug

Background: Parkinson’s Disease (PD) is characterized by both motor and non-motor symptoms. The presynaptic neuronal protein, α-Synuclein, plays a pivotal role in PD pathogenesis and is associated with both genetic and sporadic origin of the disease. Ursolic Acid (UA) is a well-known bioactive compound found in various medicinal plants, widely studied for its anti-inflammatory and antioxidant activities. Objective: In this research article, the neuroprotective potential of UA has been further explored in the Rotenone-induced mouse model of PD. Methods: To investigate our hypothesis, we have divided mice into 4 different groups, control, drug only control, Rotenone-intoxicated group, and Rotenone-intoxicated mice treated with UA. After the completion of dosing, behavioral parameters were estimated. Then mice from each group were sacrificed and the brains were isolated. Further, the biochemical tests were assayed to check the balance between the oxidative stress and endogenous anti-oxidants; and TH (Tyrosine Hydroxylase), α-Synuclein, Akt (Serine-threonine protein kinase), ERK (Extracellular signal-regulated kinase) and inflammatory parameters like Nuclear Factor-κB (NF-κB) and Tumor Necrosis Factor- α (TNF-α) were assessed using Immunohistochemistry (IHC). Western blotting was also done to check the expressions of TH and α-Synuclein. Moreover, the expression levels of PD related genes like α-Synuclein, β-Synuclein, Interleukin-1β (IL-1β), and Interleukin-10 (IL-10) were assessed by using Real-time PCR. Results: The results obtained in our study suggested that UA significantly reduced the overexpression of α-Synuclein and regulated the phosphorylation of survival-related kinases (Akt and ERK) apart from alleviating the behavioral abnormalities and protecting the dopaminergic neurons from oxidative stress and neuroinflammation. Conclusion: Thus, our study shows the neuroprotective potential of UA, which can further be explored for possible clinical intervention.

scholarly journals Alpinetin Attenuates Persistent Inflammation, Immune Suppression, and Catabolism Syndrome in a Septic Mouse Model

2021 ◽  
Vol 2021 ◽  
pp. 1-9
Author(s):  
Yukun Liu ◽  
Kang Wang ◽  
Qaunrui Feng ◽  
Yongsheng Zhang ◽  
Chuntao Wang ◽  
...  
Keyword(s):  
Oxidative Stress ◽  
Mouse Model ◽  
Immune Suppression ◽  
Antioxidant Activities ◽  
Cecal Ligation ◽  
Sham Operation ◽  
Relevant Model ◽  
Septic Mouse ◽  
Persistent Inflammation ◽  
Group 2

Patients who survive the acute phase of sepsis can progress to persistent inflammation, immunosuppression, and catabolism syndrome (PICS), which usually results in extended recovery periods and multiple complications. Alpinetin is a flavonoid isolated from Alpinia katsumadai Hayata that has been demonstrated to have anti-inflammatory, antibacterial, and antioxidant activities. The aim of this study was to investigate whether the administration of alpinetin could attenuate PICS in a septic mouse model. Mice were randomly divided into four groups: the (1) sham-operated group, (2) sham+alpinetin (1 mg/kg intravenously infused for once per day after sham operation), (3) cecal ligation and puncture (CLP), and (4) CLP+alpinetin (50 mg/kg intravenously infused for once per day after CLP). Eight days after sham operation or CLP surgery, mice were euthanized for subsequent examination. Alpinetin significantly improved the survival of septic mice. Also, it attenuated the CLP-induced persistent inflammation, immunosuppression, and catabolism syndrome. The level of plasma proinflammatory cytokines and apoptosis of T lymphocytes were obviously decreased by alpinetin as well. Moreover, oxidative stress in the organs was compelling lower in the alpinetin-treated CLP mice. In this clinically relevant model of sepsis, alpinetin ameliorates CLP-induced organ dysfunction and improves the likelihood of survival, possibly through suppressing the inflammatory response, oxidative stress, and apoptosis. These findings suggested that alpinetin could be a potential novel therapeutic approach to prevent sepsis-induced PICS.

scholarly journals Ursolic acid attenuates beta-amyloid-induced memory impairment in mice

2016 ◽  
Vol 74 (6) ◽  
pp. 482-488 ◽  
Author(s):  
Wenna Liang ◽  
Xiaoyang Zhao ◽  
Jinping Feng ◽  
Fenghua Song ◽  
Yunzhi Pan
Keyword(s):  
Oxidative Stress ◽  
Ursolic Acid ◽  
Memory Impairment ◽  
Tumor Necrosis ◽  
Therapeutic Strategy ◽  
Antioxidant Activities ◽  
Neuroprotective Effect ◽  
Amyloid Β ◽  
Memory Deficits ◽  
Memory Impairments

ABSTRACT Objective Increasing evidence demonstrates that oxidative stress and inflammatory are involved in amyloid β (Aβ)-induced memory impairments. Ursolic acid (UA), a triterpenoid compound, has potent anti-inflammatory and antioxidant activities. However, it remains unclear whether UA attenuates Aβ-induced neurotoxicity. Method The aggregated Aβ25-35 was intracerebroventricularly administered to mice. Results We found that UA significantly reversed the Aβ25-35-induced learning and memory deficits. Our results indicated that one of the potential mechanisms of the neuroprotective effect was attenuating the Aβ25-35-induced accumulation of malondialdehyde (MDA) and depletion of glutathione (GSH) in the hippocampus. Furthermore, UA significantly suppressed the upregulation of IL-1β, IL-6, and tumor necrosis-α factor levels in the hippocampus of Aβ25-35-treated mice. Conclusion These findings suggest that UA prevents memory impairment through amelioration of oxidative stress, inflammatory response and may offer a novel therapeutic strategy for the treatment of Alzheimer’s disease.

scholarly journals Oral Administration of Gintonin Protects the Brains of Mice against Aβ-Induced Alzheimer Disease Pathology: Antioxidant and Anti-Inflammatory Effects

2021 ◽  
Vol 2021 ◽  
pp. 1-16
Author(s):  
Muhammad Ikram ◽  
Min Gi Jo ◽  
Tae Ju Park ◽  
Min Woo Kim ◽  
Ibrahim Khan ◽  
...  
Keyword(s):  
Oxidative Stress ◽  
Mouse Model ◽  
Amyloid Β ◽  
Microglial Cells ◽  
Heme Oxygenase 1 ◽  
Related Factor ◽  
Protective Effects ◽  
Biochemical Tests ◽  
Proinflammatory Mediators ◽  
Ad Mouse Model

The study was aimed at analyzing the protective effects of gintonin in an amyloid beta- (Aβ-) induced Alzheimer’s disease (AD) mouse model. For the development of the Aβ-induced AD mouse model, the amyloid-β (Aβ1-42) peptide was stereotaxically injected into the brains of mice. Subsequently, gintonin was administered at a dose of 100 mg/kg/day/per oral (p.o) for four weeks daily, and its effects were evaluated by using western blotting, fluorescence analysis of brain sections, biochemical tests, and memory-related behavioral evaluations. To elucidate the effects of gintonin at the mechanistic level, the activation of endogenous antioxidant mechanisms, as well as the activation of astrocytes, microglia, and proinflammatory mediators such as nuclear factor erythroid 2-related factor 2 (NRF-2) and heme oxygenase-1 (HO-1), was evaluated. In addition, microglial cells (BV-2 cells) were used to analyze the effects of gintonin on microglial activation and signaling mechanisms. Collectively, the results suggested that gintonin reduced elevated oxidative stress by improving the expression of NRF-2 and HO-1 and thereby reducing the generation of reactive oxygen species (ROS) and lipid peroxidation (LPO). Moreover, gintonin significantly suppressed activated microglial cells and inflammatory mediators in the brains of Aβ-injected mice. Our findings also indicated improved synaptic and memory functions in the brains of Aβ-injected mice after treatment with gintonin. These results suggest that gintonin may be effective for relieving AD symptoms by regulating oxidative stress and inflammatory processes in a mouse model of AD. Collectively, the findings of this preclinical study highlight and endorse the potential, multitargeted protective effects of gintonin against AD-associated oxidative damage, neuroinflammation, cognitive impairment, and neurodegeneration.

scholarly journals Artemether Activation of AMPK/GSK3β(ser9)/Nrf2 Signaling Confers Neuroprotection towards β-Amyloid-Induced Neurotoxicity in 3xTg Alzheimer’s Mouse Model

2019 ◽  
Vol 2019 ◽  
pp. 1-24 ◽  
Author(s):  
Shuai Li ◽  
Xia Zhao ◽  
Philip Lazarovici ◽  
Wenhua Zheng
Keyword(s):  
Oxidative Stress ◽  
Mouse Model ◽  
Tau Protein ◽  
Antioxidant Activities ◽  
Neuronal Cell ◽  
Temporal Correlation ◽  
Neuroprotective Effects ◽  
Hyperphosphorylated Tau Protein ◽  
Nrf2 Signaling Pathway ◽  
Anti Inflammatory

Alzheimer’s disease is a severe neurodegenerative disease. Multiple factors involving neurofibrillary tangles and amyloid-β plaques lead to the progression of the AD, generated by aggregated hyperphosphorylated Tau protein. Inflammation, mitochondrial dysfunction, and oxidative stress play a significant role in the progression of AD. It has been therefore suggested that the multifactorial nature of AD pathogenesis requires the design of antioxidant drugs with a broad spectrum of neuroprotective activities. For this reason, the use of natural products, characterized by multiple pharmacological properties is advantageous as AD-modifying drugs over the single-targeted chemicals. Artemether, a peroxide sesquiterpenoid lipid-soluble compound, has been used in the clinic as an antimalarial drug. Also, it exhibits potent anti-inflammatory and antioxidant activities. Here, we report the neuroprotective effects of Artemether towards Aβ-induced neurotoxicity in neuronal cell cultures. A temporal correlation was found between Artemether neuroprotection towards Aβ-induced neurotoxicity and AMPK/GSK3β phosphorylation activity and increased expression of the activated Nrf2 signaling pathway. In 3xTg-AD mice, Artemether attenuated learning and memory deficits, inhibited cortical neuronal apoptosis and glial activation, inhibited oxidative stress through decrease of lipid peroxidation and increased expression of SOD, and reduced Aβ deposition and tau protein phosphorylation. Moreover, in 3xTg-AD mice, Artemether induced phosphorylation of the AMPK/GSK3β pathway which activated Nrf2, increasing the level of antioxidant protein HO-1. These activities probably produced the antioxidant and anti-inflammatory effects responsible for the neuroprotective effects of Artemether in the 3xTg-AD mouse model. These findings propose Artemether as a new drug for the treatment of AD disease.

scholarly journals Polydatin Prevents Calcium Pyrophosphate Crystal-Induced Arthritis in Mice

Nutrients ◽  
2021 ◽  
Vol 13 (3) ◽  
pp. 929
Author(s):  
Francesca Oliviero ◽  
Paola Galozzi ◽  
Anna Scanu ◽  
Francesca Galuppini ◽  
Vanni Lazzarin ◽  
...  
Keyword(s):  
Mouse Model ◽  
Bioactive Compound ◽  
Tissue Expression ◽  
Calcium Pyrophosphate ◽  
Leukocyte Infiltration ◽  
Acute Arthritis ◽  
Control Drug ◽  
Secondary Outcomes ◽  
Anti Inflammatory ◽  
Crystal Induced Arthritis

Background: Polydatin is a stilbenoid with important antioxidant, anti-inflammatory, and immunomodulating properties. The aim of this study was to assess the anti-inflammatory preventive effect of polydatin in the mouse model of acute arthritis induced by calcium pyrophosphate (CPP) crystals. Methods: Acute arthritis was induced by the injection of a suspension of sterile CPP crystals into the ankle joint of Balb/c mice. Animals were randomized to receive polydatin or colchicine (the control drug) according to a prophylactic and a therapeutic protocol. The primary outcome was the variation of ankle swelling obtained after crystal injection and treatment, while histological parameters such as leukocyte infiltration, IL-1ß and CXCL1 levels and tissue expression were considered as secondary outcomes. Results: Prophylactic treatment with PD significantly diminished ankle swelling after 48 h from crystal injection. Secondary outcomes such as leukocyte infiltration, necrosis, edema, and synovitis were also decreased. PD caused a reduction in circulating levels of IL-1ß and CXCL1, as well as their tissue expression. By contrast, the therapeutic administration of PD did not have any beneficial effect. Conclusions: PD can effectively prevent acute inflammatory response to crystals in the mouse model of CPP crystal-induced arthritis. These results suggest that this bioactive compound might be used in the prevention of crystal-induced acute attacks in humans.

Sign in / Sign up

Export Citation Format

Share Document